Childhood, adolescent and young adult cancer survivors may develop treatment-induced hypothalamic-pituitary dysfunction. Because of this risk, at-risk survivors may benefit from surveillance of hypothalamic-pituitary dysfunction surveillance. This guideline describes the groups at risk and the surveillance recommended for this group
Quality of LifeAllGuidelines
IGHG Guideline on Hypothalamic-Pituitary Dysfunction
Recommendations for surveillance for hypothalamic-pituitary dysfunction in survivors
Published:
Continue reading · Quality of LifeIGHG Male Gonadotoxicity Surveillance RecommendationsRecommendations for surveillance in male survivors
who are at risk of impaired spermatogenesis, testosterone deficiency or
physical sexual dysfunction
Discussion & Questions
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Leave a Comment
No comments yet
Be the first to share your thoughts!
Related Resources
IGHG Guideline on Coronary Artery Disease Surveillance
Recommendations for surveillance for coronary artery disease in survivors
Quality of LifeAll
Read
IGHG Guideline on Hepatic Toxicity
Recommendations for surveillance for hepatic toxicity in survivors
Quality of LifeAll
Read
IGHG Guideline on Mental Health Problems
Recommendations for surveillance for mental health problems in survivors
Quality of LifeAll
Read